Patents Assigned to Photoprotective Technologies Incorporated
  • Publication number: 20230255828
    Abstract: The detailed characteristics of the red fluorescence of the human lens—that occurs at the seventh decade of life—is recognized as an example of evolutionary photobiomodulation for repair of the retina, and then used as a paradigm for extending current parametric values for reproducible photobiomodulation. The new photobiomodulation parameters involve relative intensities for wavelength bands within the range of 600 nm to 900 nm.
    Type: Application
    Filed: April 19, 2023
    Publication date: August 17, 2023
    Applicant: Photoprotective Technologies Incorporated
    Inventor: James M. Gallas
  • Publication number: 20200323686
    Abstract: The detailed characteristics of the red fluorescence of the human lens—that occurs at the seventh decade of life—is recognized as an example of evolutionary photobiomodulation for repair of the retina, and then used as a paradigm for extending current parametric values for reproducible photobiomodulation. The new photobiomodulation parameters involve relative intensities for wavelength bands within the range of 600 nm to 900 nm.
    Type: Application
    Filed: April 13, 2020
    Publication date: October 15, 2020
    Applicant: Photoprotective Technologies Incorporated
    Inventor: James M. Gallas
  • Publication number: 20200133027
    Abstract: According to the present invention, light filters are disclosed that provide photoprotection and contain fluorescent agents in that have fluorescence emission in the near infrared region of wavelengths to effect photobiological modulation (PBM) of human cells when the cells are exposed to sunlight or any artificial lighting. The fluorescent agents include endogenous compounds. The light filters include ophthalmic lenses, skin care products with or without transparent substrate and any products that are used to filter light. When used in connection with ophthalmic lenses, the ophthalmic lense provides photoprotection and photobiological modulation to the human eye.
    Type: Application
    Filed: January 30, 2018
    Publication date: April 30, 2020
    Applicant: Photoprotective Technologies Incorporated
    Inventors: James M. Gallas, Matthew T. Gordon
  • Publication number: 20190374789
    Abstract: An ophthalmic lens comprising a clear, non-tinted, solid plastic substrate and a dye suitable for undergoing fluorescence upconversion wherein said dye absorbs light in the near infrared region from 850 nm to 2500 nm and emit light in the shorter wavelength region from 650 nm to 850 nm thereby providing photobiomodulation to the eye.
    Type: Application
    Filed: June 11, 2019
    Publication date: December 12, 2019
    Applicant: Photoprotective Technologies Incorporated
    Inventor: James M. Gallas
  • Publication number: 20190212582
    Abstract: A method that uses the transmission spectrum of an opthalmic lens to generate, as output, the ratio of the average transmission of sunlight that repairs the retina to the average transmission of sunlight that causes damage to the retina. This ratio is compared with a similar ratio for the naked eye that correlates with macular degeneration and allows the user to select a ratio that extends the risk of acquiring macular degeneration by multiples of an average lifetime.
    Type: Application
    Filed: January 10, 2019
    Publication date: July 11, 2019
    Applicant: Photoprotective Technologies incorporated
    Inventor: James Martin Gallas
  • Publication number: 20180024383
    Abstract: According to the present invention, light filters are disclosed that provide photoprotection and contain fluorescent agents that have fluorescence emission in the near infrared region of wavelengths to effect photobiological modulation (PBM) of human cells when the cells are exposed to sunlight or any artificial lighting. The fluorescent agents include endogenous compounds. The light filters include ophthalmic lenses, skin care products with or without transparent substrate and any products that are used to filter light. When used in connection with ophthalmic lenses, the ophthalmic lense provides photoprotection and photobiological modulation to the human eye.
    Type: Application
    Filed: June 27, 2017
    Publication date: January 25, 2018
    Applicant: Photoprotective Technologies Incorporated
    Inventors: James M. Gallas, Matthew T. Gordon
  • Publication number: 20170299897
    Abstract: Ophthalmic lenses and light filters containing special additives that have fluorescence emission in the near infrared region of wavelengths—in order to enhance phototherapy for the human eye when it is exposed to sunlight and artificial lighting.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 19, 2017
    Applicant: Photoprotective Technologies Incorporated
    Inventor: James M. Gallas
  • Patent number: 9726910
    Abstract: Ophthalmic lenses and light filters containing special additives that have fluorescence emission in the near infrared region of wavelengths—in order to enhance phototherapy for the human eye when it is exposed to sunlight and artificial lighting.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: August 8, 2017
    Assignee: PHOTOPROTECTIVE TECHNOLOGIES INCORPORATED
    Inventor: James Martin Gallas
  • Patent number: 5116884
    Abstract: A hydrophilic contact lens is disclosed incorporating melanin that protects the eye from harmful radiation and superoxide.
    Type: Grant
    Filed: February 16, 1990
    Date of Patent: May 26, 1992
    Assignee: Photoprotective Technology Incorporated
    Inventor: James M. Gallas
  • Patent number: 5112883
    Abstract: The present invention is directed to a medium incorporating melanin for radiation protection.
    Type: Grant
    Filed: November 9, 1990
    Date of Patent: May 12, 1992
    Assignee: Photoprotective Technologies Incorporated
    Inventor: James M. Gallas